ACE2 and COVID-19: TheN‐cap makes the difference: Aiming at the development of potential COVID‐19 drugs distorting the interaction between the SARS‐CoV‐2 spike protein and human ACE2, a series of N‐capped peptides derived from the α1‐helix of ACE2 were prepared to increase the α‐helical content.